Mei-Kuang Chen Selected Research

Mei-Kuang Chen Research Topics

Disease

19	Neoplasms (Cancer) 03/2024 - 12/2015
9	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2014
6	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 12/2014
6	Fatigue 11/2021 - 12/2014
3	Triple Negative Breast Neoplasms 09/2023 - 09/2014
2	Adenocarcinoma 01/2021 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 02/2016
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Inflammatory Breast Neoplasms 01/2022
1	Bites and Stings (Sting) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Pain (Aches) 01/2020
1	Chronic Pain 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Genomic Instability 01/2018
1	Anhedonia 01/2016
1	Body Weight (Weight, Body) 01/2016

Drug/Important Bio-Agent (IBA)

13	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 02/2016
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2016
5	Phosphotransferases (Kinase)IBA 10/2022 - 01/2016
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2022 - 02/2016
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2016
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2019
3	olaparibIBA 01/2021 - 02/2016
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2024 - 01/2020
2	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 05/2016 - 12/2014
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 03/2024
1	erastinIBA 03/2024
1	Voltage-Dependent Anion ChannelsIBA 03/2024
1	Deubiquitinating EnzymesIBA 09/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Proline (L-Proline)FDA Link 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Nuclear Export Signals (Nuclear Export Signal)IBA 01/2023
1	Positive Transcriptional Elongation Factor BIBA 10/2022
1	PlatinumIBA 10/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Gemcitabine FDA Link 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	talazoparibIBA 01/2020
1	nedaplatinIBA 12/2019
1	Poly Adenosine Diphosphate RiboseIBA 12/2019
1	poly ADP-ribose glycohydrolaseIBA 12/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	LipidsIBA 01/2019
1	fluzoparibIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Immune Checkpoint InhibitorsIBA 07/2017
1	Flucytosine (Ancobon)FDA Link 01/2017
1	Angiogenic ProteinsIBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	EndostatinsIBA 01/2017
1	Cytosine DeaminaseIBA 01/2017
1	uracil phosphoribosyltransferaseIBA 01/2017
1	ResveratrolIBA 01/2017
1	Glutathione (Reduced Glutathione)IBA 05/2016
1	SaccharinIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	Heme (Haem)IBA 12/2015
1	AndrogensIBA 12/2015

Therapy/Procedure

11	Therapeutics 11/2021 - 09/2014
6	Radiotherapy 11/2021 - 12/2014
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Immunotherapy 01/2022
1	Pain Management 01/2020